Bharat Biotech gets CDSCO approval for Phase III Covid-19 vaccine trials

Derived from a strain of SARS-CoV-2 virus, Covaxin uses adjuvant Alhydroxiquim-II to boost immune response. Credit: Gedesby1989 on Pixabay.



  • Bharat Biotech